Michael J. Tokich - Sep 10, 2024 Form 4 Insider Report for STERIS plc (STE)

Role
Sr. Vice Pres., CFO
Signature
/s/ John P. Ubbing, Authorized Representative under Power of Attorney
Stock symbol
STE
Transactions as of
Sep 10, 2024
Transactions value $
-$3,098,023
Form type
4
Date filed
9/12/2024, 04:31 PM
Previous filing
Jun 6, 2024
Next filing
Sep 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STE Ordinary Shares Award $2.66M +23.3K +54.35% $114.22 66.3K Sep 10, 2024 Direct
transaction STE Ordinary Shares Sale -$5.76M -23.3K -35.21% $247.00 42.9K Sep 10, 2024 Direct F1, F2
holding STE Ordinary Shares 3.57K Sep 10, 2024 See Footnote Below F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STE Employee Stock Option (right to buy) Options Exercise $0 -23.3K -50% $0.00 23.3K Sep 10, 2024 Ordinary Shares 23.3K $114.22 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Price reflects a weighted average sale price for multiple transactions ranging from $247.00 to $247.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 As of September 10, 2024, 8,286 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027.
F3 Units representing 3,566 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of September 10, 2024.
F4 This option to purchase 46,664 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 46,664 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.